Clinical Trial Update: Effect of Eplerenone on Endothelial Function in Patients With Stable Coronary Heart Disease

View source ↗

Summary

A completed clinical trial evaluating the effect of the mineralocorticoid receptor antagonist eplerenone on endothelial function in patients with stable coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: University of Zurich | Conditions: Coronary Artery Disease | Status: COMPLETED